These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 7710378)
41. Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease. Marshall GA; Kaufer DI; Lopez OL; Rao GR; Hamilton RL; DeKosky ST J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1396-400. PubMed ID: 15377684 [TBL] [Abstract][Full Text] [Related]
42. Anosognosia and depression in patients with Alzheimer's dementia. Verhülsdonk S; Quack R; Höft B; Lange-Asschenfeldt C; Supprian T Arch Gerontol Geriatr; 2013; 57(3):282-7. PubMed ID: 23597486 [TBL] [Abstract][Full Text] [Related]
43. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226 [TBL] [Abstract][Full Text] [Related]
44. Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease. Avondino E; Antoine P J Alzheimers Dis; 2016; 50(1):89-99. PubMed ID: 26638866 [TBL] [Abstract][Full Text] [Related]
45. Visual attention deficits in Alzheimer's disease: relationship to HMPAO SPECT cortical hypoperfusion. Vasquez BP; Buck BH; Black SE; Leibovitch FS; Lobaugh NJ; Caldwell CB; Behrmann M Neuropsychologia; 2011 Jun; 49(7):1741-50. PubMed ID: 21377483 [TBL] [Abstract][Full Text] [Related]
47. A SPECT study of parkinsonism in Alzheimer's disease. Starkstein SE; Vazquez S; Merello M; Tesón A; Petracchi M; Leiguarda R J Neuropsychiatry Clin Neurosci; 1995; 7(3):308-13. PubMed ID: 7580189 [TBL] [Abstract][Full Text] [Related]
48. Two domains of anosognosia in Alzheimer's disease. Starkstein SE; Sabe L; Chemerinski E; Jason L; Leiguarda R J Neurol Neurosurg Psychiatry; 1996 Nov; 61(5):485-90. PubMed ID: 8937343 [TBL] [Abstract][Full Text] [Related]
49. Relationship between delusions and regional cerebral blood flow in Alzheimer's disease. Nakano S; Yamashita F; Matsuda H; Kodama C; Yamada T Dement Geriatr Cogn Disord; 2006; 21(1):16-21. PubMed ID: 16254426 [TBL] [Abstract][Full Text] [Related]
50. Cross domain self-monitoring in anosognosia for memory loss in Alzheimer's disease. Chapman S; Colvin LE; Vuorre M; Cocchini G; Metcalfe J; Huey ED; Cosentino S Cortex; 2018 Apr; 101():221-233. PubMed ID: 29518705 [TBL] [Abstract][Full Text] [Related]
51. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381 [TBL] [Abstract][Full Text] [Related]
52. Determinants of quantitative spectral electroencephalography in early Alzheimer's disease: cognitive function, regional cerebral blood flow, and computed tomography. Claus JJ; Ongerboer De Visser BW; Bour LJ; Walstra GJ; Hijdra A; Verbeeten B; Van Royen EA; Kwa VI; van Gool WA Dement Geriatr Cogn Disord; 2000; 11(2):81-9. PubMed ID: 10705165 [TBL] [Abstract][Full Text] [Related]
53. Relationship between regional cerebral blood flow and verbal fluency in Alzheimer's disease. Kitabayashi Y; Ueda H; Tsuchida H; Iizumi H; Narumoto J; Nakamura K; Kita H; Fukui K Psychiatry Clin Neurosci; 2001 Oct; 55(5):459-63. PubMed ID: 11555340 [TBL] [Abstract][Full Text] [Related]
54. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. Waldemar G; Christiansen P; Larsson HB; Høgh P; Laursen H; Lassen NA; Paulson OB J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1458-65. PubMed ID: 7798973 [TBL] [Abstract][Full Text] [Related]
55. Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia. Battistin L; Pizzolato G; Dam M; Ponza I; Borsato N; Zanco PL; Ferlin G Eur Neurol; 1990; 30(5):296-301. PubMed ID: 2269322 [TBL] [Abstract][Full Text] [Related]
56. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086 [TBL] [Abstract][Full Text] [Related]
57. The investigation of Alzheimer's disease with single photon emission tomography. Burns A; Philpot MP; Costa DC; Ell PJ; Levy R J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):248-53. PubMed ID: 2467967 [TBL] [Abstract][Full Text] [Related]
58. Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain spect. Lee BF; Liu CK; Tai CT; Chiu NT; Liu GC; Yu HS; Pai MC Kaohsiung J Med Sci; 2001 Aug; 17(8):394-400. PubMed ID: 11715838 [TBL] [Abstract][Full Text] [Related]
59. Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and Yoshida T; Mori T; Shimizu H; Yoshino Y; Sonobe N; Matsumoto T; Kikuchi K; Miyagawa M; Iga J; Mochizuki T; Ueno SI Int J Geriatr Psychiatry; 2017 Apr; 32(4):407-413. PubMed ID: 27094214 [TBL] [Abstract][Full Text] [Related]
60. SPECT findings on psychosis in Alzheimer's disease. Kotrla KJ; Chacko RC; Harper RG; Jhingran S; Doody R Am J Psychiatry; 1995 Oct; 152(10):1470-5. PubMed ID: 7573586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]